Cogent Biosciences will present a poster on bezuclastinib at the AAAAI Annual Meeting, focusing on long-term symptomatic benefits in NonAdvSM patients.
SOPHiA GENETICS and Boundless Bio collaborate with Precision for Medicine to validate a novel clinical trial assay for detecting extrachromosomal DNA (ecDNA).
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.